Tradestie Institutional Equity Comparison Engine
HHS vs DLX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DLX Overall Edge
DLX Captures Institutional Edge (4โ0 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Deluxe Corporation (DLX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, HHS trades at 14.3x Forward P/E with -3.2% operating margin (-1.7% YoY revenue) versus DLX at 6.5x Forward P/E and 12.8% operating margin (+2.5% YoY). In options structure, HHS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DLX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
DLX
HHS 14.3x vs DLX 6.5x Fwd P/E
Growth & Margin Winner
DLX
Op Margin -3.2% vs 12.8% ยท YoY -1.7% vs +2.5%
Momentum & Technical Winner
DLX
1Y +8.8% vs +32.3% ยท 52W Pos 69% vs 63%
Options & Structure Winner
DLX
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (<1st %ile IV)
HHS
US Equity
Harte Hanks, Inc.
Services-Direct Mail Advertising Services
$3.84
-4.24% 1D
Market Cap
$30.0M
1M Return
-10.49%
1Y Return
+8.78%
Forward P/E
14.3x
Unified AI Score
61.8 / 100
BUY
Tech 76.0
Fund 61.0
Flow 50.0
Mom 54.0
DLX
NYSE
Deluxe Corporation
Blankbooks, Looseleaf Binders & Bookbindg & Relatd Work
$27.05
+1.01% 1D
Market Cap
$1.2B
1M Return
+16.7%
1Y Return
+32.34%
Forward P/E
6.5x
Unified AI Score
31.4 / 100
SELL
Tech 50.0
Fund 28.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
HHS +8.78%
DLX +32.34%
Spread: +2.4 pp (HHS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
HHS TTM Op. Margin: -3.2%
DLX TTM Op. Margin: 12.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HHS vs DLX. Trailing 12-month operating profitability (HHS -3.2% vs DLX 12.8%) and valuation multiples (HHS 14.3x vs DLX 6.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | HHS | DLX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $30.0M | $1.2B | Larger Scale | DLX |
| Trailing P/E Ratio Valuation | 14.3x | 15.5x | Lower Multiple | HHS |
| Forward P/E Ratio Valuation | 14.3x | 6.5x | Lower Multiple | DLX |
| Revenue Growth (YoY) Growth | -1.7% | +2.5% | Higher Growth | DLX |
| Operating Margin (TTM) Profitability | -3.2% | 12.8% | Higher Margin | DLX |
| Net Profit Margin Profitability | -3.7% | 3.8% | Higher Margin | DLX |
| Return on Equity (ROE) Capital Efficiency | -30.4% | 11.6% | Higher ROE | DLX |
| 52-Week Range Position Momentum | 69% ($2โ$5) | 63% ($19โ$32) | Stronger Trend | HHS |
| Beta / 30D Volatility Risk Regime | 0.49ฮฒ ยท 46% Vol | -0.45ฮฒ ยท 75% Vol | Lower Realized Risk | HHS |
| Unified Institutional Score Composite Signal | 61.8 / 100 (BUY) | 31.4 / 100 (SELL) | Higher Composite | HHS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full HHS vs DLX Buy Guide
HHS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
DLX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither HHS nor DLX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.